Blujepa (Gepotidacin) Adaptive Clinical Decision Assessment

Choose a track and manage high-impact prescribing decisions for uUTI or gonorrhea

Medical content baseline: BLUJEPA prescribing information revision 2/2026, with indication-specific dosing and safety reinforcement checkpoints.

Clinical Scenario: This adaptive module begins with scenario selection, then branches based on your clinical decisions. You will encounter remediation checkpoints and track-specific takeaways.
2
Tracks
0.5
CE Credits*
70%
Passing Score

*Accreditation is pending. CE credit values shown are for MVP demonstration and are not yet formally accredited.